-
1
-
-
75949128633
-
Antiplatelet therapies for the treatment of cardiovascular disease
-
Michelson AD: Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov 2010;9:154-169.
-
(2010)
Nat. Rev. Drug Discov.
, vol.9
, pp. 154-169
-
-
Michelson, A.D.1
-
2
-
-
70450199115
-
2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update)
-
Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE Jr, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO: 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009;54:2205-2241.
-
(2009)
J. Am. Coll. Cardiol.
, vol.54
, pp. 2205-2241
-
-
Kushner, F.G.1
Hand, M.2
Smith Jr., S.C.3
King III, S.B.4
Anderson, J.L.5
Antman, E.M.6
Bailey, S.R.7
Bates, E.R.8
Blankenship, J.C.9
Casey Jr., D.E.10
Green, L.A.11
Hochman, J.S.12
Jacobs, A.K.13
Krumholz, H.M.14
Morrison, D.A.15
Ornato, J.P.16
Pearle, D.L.17
Peterson, E.D.18
Sloan, M.A.19
Whitlow, P.L.20
Williams, D.O.21
more..
-
3
-
-
68849107287
-
Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction
-
Rabbani LE, Iyengar S, Dangas GD, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Stant J, Fahy M, Lansky AJ, Mehran R, Stone GW: Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction. J Interv Cardiol 2009;22:378-384.
-
(2009)
J. Interv. Cardiol.
, vol.22
, pp. 378-384
-
-
Rabbani, L.E.1
Iyengar, S.2
Dangas, G.D.3
Grines, C.L.4
Cox, D.A.5
Garcia, E.6
Tcheng, J.E.7
Griffin, J.J.8
Guagliumi, G.9
Stuckey, T.10
Turco, M.11
Stant, J.12
Fahy, M.13
Lansky, A.J.14
Mehran, R.15
Stone, G.W.16
-
4
-
-
41349113774
-
Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome
-
Frere C, Cuisset T, Morange PE, Quilici J, Camoin-Jau L, Saut N, Faille D, Lambert M, Juhan-Vague I, Bonnet JL, Alessi MC: Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome. Am J Cardiol 2008;101:1088-1093.
-
(2008)
Am. J. Cardiol.
, vol.101
, pp. 1088-1093
-
-
Frere, C.1
Cuisset, T.2
Morange, P.E.3
Quilici, J.4
Camoin-Jau, L.5
Saut, N.6
Faille, D.7
Lambert, M.8
Juhan-Vague, I.9
Bonnet, J.L.10
Alessi, M.C.11
-
5
-
-
46849109542
-
Coexisting polymorphisms of P2Y12 and CYP2C19 genes as a risk factor for persistent platelet activation with clopidogrel
-
Malek LA, Kisiel B, Spiewak M, Grabowski M, Filipiak KJ, Kostrzewa G, Huczek Z, Ploski R, Opolski G: Coexisting polymorphisms of P2Y12 and CYP2C19 genes as a risk factor for persistent platelet activation with clopidogrel. Circ J 2008;72:1165-1169.
-
(2008)
Circ. J.
, vol.72
, pp. 1165-1169
-
-
Malek, L.A.1
Kisiel, B.2
Spiewak, M.3
Grabowski, M.4
Filipiak, K.J.5
Kostrzewa, G.6
Huczek, Z.7
Ploski, R.8
Opolski, G.9
-
6
-
-
58249135635
-
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: A cohort study
-
Collet JP, Hulot JS, Pena A, Villard E, Esteve JB, Silvain J, Payot L, Brugier D, Cayla G, Beygui F, Bensimon G, Funck-Brentano C, Montalescot G: Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet 2009;373:309-317.
-
(2009)
Lancet
, vol.373
, pp. 309-317
-
-
Collet, J.P.1
Hulot, J.S.2
Pena, A.3
Villard, E.4
Esteve, J.B.5
Silvain, J.6
Payot, L.7
Brugier, D.8
Cayla, G.9
Beygui, F.10
Bensimon, G.11
Funck-Brentano, C.12
Montalescot, G.13
-
7
-
-
58749090547
-
French registry of acute ST-elevation and non-ST-elevation myocardial infarction (FAST-MI) investigators: Genetic determinants of response to clopidogrel and cardiovascular events
-
Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, Steg PG, Ferrières J, Danchin N, Becquemont L; French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators: Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 2009;360:363-375.
-
(2009)
N. Engl. J. Med.
, vol.360
, pp. 363-375
-
-
Simon, T.1
Verstuyft, C.2
Mary-Krause, M.3
Quteineh, L.4
Drouet, E.5
Méneveau, N.6
Steg, P.G.7
Ferrières, J.8
Danchin, N.9
Becquemont, L.10
-
8
-
-
61349191612
-
Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis
-
Giusti B, Gori AM, Marcucci R, Saracini C, Sestini I, Paniccia R, Buonamici P, Antoniucci D, Abbate R, Gensini GF: Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis. Am J Cardiol 2009;103:806-811.
-
(2009)
Am. J. Cardiol.
, vol.103
, pp. 806-811
-
-
Giusti, B.1
Gori, A.M.2
Marcucci, R.3
Saracini, C.4
Sestini, I.5
Paniccia, R.6
Buonamici, P.7
Antoniucci, D.8
Abbate, R.9
Gensini, G.F.10
-
9
-
-
65249145201
-
Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention
-
Sibbing D, Stegherr J, Latz W, Koch W, Mehilli J, Dörrler K, Morath T, Schömig A, Kastrati A, von Beckerath N: Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention. Eur Heart J 2009;30:916-922.
-
(2009)
Eur. Heart J.
, vol.30
, pp. 916-922
-
-
Sibbing, D.1
Stegherr, J.2
Latz, W.3
Koch, W.4
Mehilli, J.5
Dörrler, K.6
Morath, T.7
Schömig, A.8
Kastrati, A.9
Von Beckerath, N.10
-
10
-
-
0033609457
-
Can coronary blood flow velocity pattern after primary percutaneous transluminal coronary angiography predict recovery of regional left ventricular function in patients with acute myocardial infarction?
-
Kawamoto T, Yoshida K, Akasaka T, Hozumi T, Takagi T, Kaji S, Ueda Y: Can coronary blood flow velocity pattern after primary percutaneous transluminal coronary angiography predict recovery of regional left ventricular function in patients with acute myocardial infarction? Circulation 1999;100:339-345.
-
(1999)
Circulation
, vol.100
, pp. 339-345
-
-
Kawamoto, T.1
Yoshida, K.2
Akasaka, T.3
Hozumi, T.4
Takagi, T.5
Kaji, S.6
Ueda, Y.7
-
11
-
-
0033809487
-
Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction
-
Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, Matsui H, Toki Y, Ito T, Hayakawa T: Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000;36:1202-1209.
-
(2000)
J. Am. Coll. Cardiol.
, vol.36
, pp. 1202-1209
-
-
Morishima, I.1
Sone, T.2
Okumura, K.3
Tsuboi, H.4
Kondo, J.5
Mukawa, H.6
Matsui, H.7
Toki, Y.8
Ito, T.9
Hayakawa, T.10
-
12
-
-
0242552079
-
Primary angioplasty in myocardial infarction (PAMI) investigators: Clinical and angiographic correlates and outcomes of suboptimal coronary flow in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
-
Mehta RH, Harjai KJ, Cox D, Stone GW, Brodie B, Boura J, O'Neill W, Grines CL; Primary Angioplasty in Myocardial Infarction (PAMI) Investigators: Clinical and angiographic correlates and outcomes of suboptimal coronary flow in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol 2003;42:1739-1746.
-
(2003)
J. Am. Coll. Cardiol.
, vol.42
, pp. 1739-1746
-
-
Mehta, R.H.1
Harjai, K.J.2
Cox, D.3
Stone, G.W.4
Brodie, B.5
Boura, J.6
O'Neill, W.7
Grines, C.L.8
-
13
-
-
1442311386
-
Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failure
-
De Luca G, van't Hof AW, de Boer MJ, Hoorntje JC, Gosselink AT, Dambrink JH, Ottervanger JP, Zijlstra F, Suryapranata H: Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failure. Circulation 2004;109:958-961.
-
(2004)
Circulation
, vol.109
, pp. 958-961
-
-
De Luca, G.1
Van't Hof, A.W.2
De Boer, M.J.3
Hoorntje, J.C.4
Gosselink, A.T.5
Dambrink, J.H.6
Ottervanger, J.P.7
Zijlstra, F.8
Suryapranata, H.9
-
14
-
-
1542409911
-
Impact of microvascular dysfunction on left ventricular remodelling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction
-
Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, Antoniucci D: Impact of microvascular dysfunction on left ventricular remodelling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004;109:1121-1126.
-
(2004)
Circulation
, vol.109
, pp. 1121-1126
-
-
Bolognese, L.1
Carrabba, N.2
Parodi, G.3
Santoro, G.M.4
Buonamici, P.5
Cerisano, G.6
Antoniucci, D.7
-
15
-
-
0033822124
-
Myocardial infarction redefined - A consensus document of the joint European society of cardiology/American college of cardiology committee for the redefinition of myocardial infarction
-
Joint European Society of Cardiology/Amercian College of Cardiology Committee
-
The Joint European Society of Cardiology/Amercian College of Cardiology Committee: Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-1513.
-
(2000)
Eur. Heart J.
, vol.21
, pp. 1502-1513
-
-
-
16
-
-
0023258694
-
Thrombolysis in myocardial infarction (TIMI) trial, phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge
-
Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, et al: Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge. Circulation 1987;76:142-154.
-
(1987)
Circulation
, vol.76
, pp. 142-154
-
-
Chesebro, J.H.1
Knatterud, G.2
Roberts, R.3
Borer, J.4
Cohen, L.S.5
Dalen, J.6
Dodge, H.T.7
Francis, C.K.8
Hillis, D.9
Ludbrook, P.10
-
17
-
-
33747874088
-
A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: The ALBION (assessment of the best loading dose of clopidogrel to blunt platelet activation, inflammation and ongoing necrosis) trial
-
ALBION Trial Investigators
-
Montalescot G, Sideris G, Meuleman C, Baldit-Sollier C, Lellouche N, Steg PG, Slama M, Milleron O, Collet JP, Henry P, Beygui F, Drouet L; ALBION Trial Investigators: A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. J Am Coll Cardiol 2006;48:931-938.
-
(2006)
J. Am. Coll. Cardiol.
, vol.48
, pp. 931-938
-
-
Montalescot, G.1
Sideris, G.2
Meuleman, C.3
Baldit-Sollier, C.4
Lellouche, N.5
Steg, P.G.6
Slama, M.7
Milleron, O.8
Collet, J.P.9
Henry, P.10
Beygui, F.11
Drouet, L.12
-
18
-
-
67849083515
-
Usefulness of pretreatment with high-dose clopidogrel in patients undergoing primary angioplasty for ST-elevation myocardial infarction
-
Fefer P, Hod H, Hammerman H, Segev A, Beinart R, Boyko V, Behar S, Matetzky S: Usefulness of pretreatment with high-dose clopidogrel in patients undergoing primary angioplasty for ST-elevation myocardial infarction. Am J Cardiol 2009;104:514-518.
-
(2009)
Am. J. Cardiol.
, vol.104
, pp. 514-518
-
-
Fefer, P.1
Hod, H.2
Hammerman, H.3
Segev, A.4
Beinart, R.5
Boyko, V.6
Behar, S.7
Matetzky, S.8
-
19
-
-
58749094444
-
Cytochrome p-450 polymorphisms and response to clopidogrel
-
Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, Sabatine MS: Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 2009;360:354-362.
-
(2009)
N. Engl. J. Med.
, vol.360
, pp. 354-362
-
-
Mega, J.L.1
Close, S.L.2
Wiviott, S.D.3
Shen, L.4
Hockett, R.D.5
Brandt, J.T.6
Walker, J.R.7
Antman, E.M.8
Macias, W.9
Braunwald, E.10
Sabatine, M.S.11
-
20
-
-
78650413883
-
CYP2C19 and clinical outcomes with clopidogrel: A collaborative meta-analysis
-
Orlando
-
Mega JL: CYP2C19 and clinical outcomes with clopidogrel: a collaborative meta-analysis. American Heart Association Conference, Orlando, 2009.
-
(2009)
American Heart Association Conference
-
-
Mega, J.L.1
-
21
-
-
67649654260
-
Antiplatelet drug 'resistance'. Part 1: Mechanisms and clinical measurements
-
Sweeny JM, Gorog DA, Fuster V: Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements. Nat Rev Cardiol 2009;6:273-82.5.
-
(2009)
Nat. Rev. Cardiol.
, vol.6
, pp. 273-825
-
-
Sweeny, J.M.1
Gorog, D.A.2
Fuster, V.3
-
22
-
-
66349133650
-
Cytochrome P450 genetic polymorphisms and the response to prasugrel: Relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes
-
Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias WL, Braunwald E, Sabatine MS: Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation 2009;119:2553-2560.
-
(2009)
Circulation
, vol.119
, pp. 2553-2560
-
-
Mega, J.L.1
Close, S.L.2
Wiviott, S.D.3
Shen, L.4
Hockett, R.D.5
Brandt, J.T.6
Walker, J.R.7
Antman, E.M.8
Macias, W.L.9
Braunwald, E.10
Sabatine, M.S.11
-
23
-
-
70149101223
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
-
PLATO Investigators
-
Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators, Freij A, Thorsén M: Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-1057.
-
(2009)
N. Engl. J. Med.
, vol.361
, pp. 1045-1057
-
-
Wallentin, L.1
Becker, R.C.2
Budaj, A.3
Cannon, C.P.4
Emanuelsson, H.5
Held, C.6
Horrow, J.7
Husted, S.8
James, S.9
Katus, H.10
Mahaffey, K.W.11
Scirica, B.M.12
Skene, A.13
Steg, P.G.14
Storey, R.F.15
Harrington, R.A.16
Freij, A.17
Thorsén, M.18
-
24
-
-
73149118496
-
* 2 genotype: First experience in patients
-
* 2 genotype: first experience in patients. J Thromb Haemost 2010;8:43-53.
-
(2010)
J. Thromb. Haemost.
, vol.8
, pp. 43-53
-
-
Gurbel, P.A.1
Blinden, K.P.2
Antonino, M.J.3
Stephens, G.4
Gretler, D.D.5
Jurek, M.M.6
Pakyz, R.E.7
Shuldiner, A.R.8
Conley, P.B.9
Tantry, U.S.10
-
25
-
-
73549106603
-
Evaluation of platelet inhibition by tirofiban in patients stratified according to aspirin and clopidogrel responsiveness: The 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel)
-
3T/2R Investigators
-
Campo G, Valgimigli M, Frangione A, Luccarelli S, Cangiano E, Cavazza C, Fileti L, Ferrari R; 3T/2R Investigators: Evaluation of platelet inhibition by tirofiban in patients stratified according to aspirin and clopidogrel responsiveness: the 3T/2R (Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel). J Am Coll Cardiol 2010;55:255-256.
-
(2010)
J. Am. Coll. Cardiol.
, vol.55
, pp. 255-256
-
-
Campo, G.1
Valgimigli, M.2
Frangione, A.3
Luccarelli, S.4
Cangiano, E.5
Cavazza, C.6
Fileti, L.7
Ferrari, R.8
|